Molekule Group, Inc. Quarterly Income Tax Expense (Benefit) in USD from Q1 2022 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Molekule Group, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q1 2022 to Q1 2023.
  • Molekule Group, Inc. Income Tax Expense (Benefit) for the quarter ending March 31, 2023 was $0.000, a 100% decline year-over-year.
  • Molekule Group, Inc. annual Income Tax Expense (Benefit) for 2022 was $501K, a 56.6% increase from 2021.
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2023 $0 -$92.8K -100% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-15
Q1 2022 $92.8K Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.